Company Profiles

driven by the PitchBook Platform

Telormedix

Description

Developer of immune drugs for the treatment of cancer. The company offers therapeutics that targets immunity and the role of innate immune system to treat cancer and autoimmune diseases.

2007

Founded

OOB

Status

1-10

Employees

Out of Business

Latest Deal Type

$33.6M

Total Amount Raised

Description

Developer of immune drugs for the treatment of cancer. The company offers therapeutics that targets immunity and the role of innate immune system to treat cancer and autoimmune diseases.

Website:

www.telormedix.com

Ownership Status

Out of business

Financing Status

Formerly VC-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

Via della Posta 10 6934 BioggioSwitzerland
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Telormedix's full profile, request a free trial.

    Telormedix Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Telormedix Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Roberto MajFounder & Head, Drug Development
    Raffaella PozziHead, Clinical Operations
    Wylinn Boey Ph.DVice President, Marketing & Strategic Planning
    Roberto Maj Founder & Head, Drug Development
    Raffaella Pozzi Head, Clinical Operations
    Wylinn Boey Ph.D Vice President, Marketing & Strategic Planning
    Request full access to PitchBook